BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 27188965)

  • 1. Patent foramen ovale.
    Homma S; Messé SR; Rundek T; Sun YP; Franke J; Davidson K; Sievert H; Sacco RL; Di Tullio MR
    Nat Rev Dis Primers; 2016 Jan; 2():15086. PubMed ID: 27188965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances and Ongoing Controversies in Patent Foramen Ovale Closure and Cryptogenic Stroke.
    Gonzalez JB; Testai FD
    Neurol Clin; 2021 Feb; 39(1):51-69. PubMed ID: 33223089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent foramen ovale and cryptogenic stroke: a matter of age?
    Handke M; Harloff A; Bode C; Geibel A
    Semin Thromb Hemost; 2009 Jul; 35(5):505-14. PubMed ID: 19739041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism?
    Rigatelli G; Aggio S; Cardaioli P; Braggion G; Giordan M; Dell'avvocata F; Chinaglia M; Rigatelli G; Roncon L; Chen JP
    JACC Cardiovasc Interv; 2009 Jul; 2(7):655-62. PubMed ID: 19628189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent Foramen Ovale and Stroke.
    Sun YP; Homma S
    Circ J; 2016 Jul; 80(8):1665-73. PubMed ID: 27334127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent foramen ovale (PFO): is there life before death in the presence of PFO?
    Seiler C
    Eur J Clin Invest; 2015 Aug; 45(8):875-82. PubMed ID: 26017145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent foramen ovale and cryptogenic stroke: from studies to clinical practice: Position paper of the Italian Chapter, International Society Cardiovascular Ultrasound.
    Savino K; Maiello M; Pelliccia F; Ambrosio G; Palmiero P
    Int J Clin Pract; 2016 Aug; 70(8):641-8. PubMed ID: 27384340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.
    Wessler BS; Thaler DE; Ruthazer R; Weimar C; Di Tullio MR; Elkind MS; Homma S; Lutz JS; Mas JL; Mattle HP; Meier B; Nedeltchev K; Papetti F; Di Angelantonio E; Reisman M; Serena J; Kent DM
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):125-31. PubMed ID: 24214884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale and cryptogenic stroke.
    Nakanishi K; Yoshiyama M; Homma S
    Trends Cardiovasc Med; 2017 Nov; 27(8):575-581. PubMed ID: 28709812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent foramen ovale and stroke in childhood: A systematic review of the literature.
    Khan R; Chan AK; Mondal TK; Paes BA;
    Eur J Paediatr Neurol; 2016 Jul; 20(4):500-11. PubMed ID: 27169856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aspects of paradoxical embolism.
    Lehmeyer S; Lindhoff-Last E
    Vasa; 2011 Jan; 40(1):31-40. PubMed ID: 21283971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter closure of patent foramen ovale: Current evidence and future perspectives.
    Akagi T
    J Cardiol; 2021 Jan; 77(1):3-9. PubMed ID: 33144025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Transcatheter Closure of Patent Foramen Ovale.
    Neill J; Lin CH
    Methodist Debakey Cardiovasc J; 2017; 13(3):152-159. PubMed ID: 29744000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure?
    Rigatelli G; Dell'Avvocata F; Giordan M; Braggion G; Aggio S; Chinaglia M; Roncon L; Cardaioli P; Chen JP
    J Interv Cardiol; 2009 Aug; 22(4):398-403. PubMed ID: 19515082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFO: Button me up, but wait … Comprehensive evaluation of the patient.
    Pizzino F; Khandheria B; Carerj S; Oreto G; Cusmà-Piccione M; Todaro MC; Oreto L; Vizzari G; Di Bella G; Zito C
    J Cardiol; 2016 Jun; 67(6):485-92. PubMed ID: 26917197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic features of PFOs and paradoxical embolism: a complicated puzzle.
    Aggeli C; Verveniotis A; Andrikopoulou E; Vavuranakis E; Toutouzas K; Tousoulis D
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1849-1861. PubMed ID: 29956022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent Foramen Ovale: Stroke and Device Closure.
    Suradi HS; Hijazi ZM
    Cardiol Clin; 2016 May; 34(2):231-40. PubMed ID: 27150171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events.
    Wawrzyńczyk M; Gałeczka M; Karwot B; Knop M; Białkowski J
    Kardiol Pol; 2016; 74(4):385-9. PubMed ID: 26412471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patent foramen ovale and ischemic stroke.
    Larrue V; Massabuau P
    Minerva Med; 2012 Jun; 103(3):199-207. PubMed ID: 22653100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.